Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana-Marija Sulic

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Investigational Drugs|May 9, 2014
Current status of drugs in development for celiac diseaseKalle Kurppa, Minna Hietikko, Ana-Marija Sulic, et al.
Expert Opinion on Therapeutic Targets|November 21, 2014
Transglutaminase as a therapeutic target for celiac diseaseAna-Marija Sulic, Kalle Kurppa, Tiina Rauhavirta, et al.
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|October 31, 2020
System-level analyses of keystone genes required for mammalian tooth developmentOuti Hallikas, Rishi Das Roy, Mona M Christensen, et al.
The International Journal of Developmental Biology|May 21, 2024
Wnt target gene Ascl4 is dispensable for skin appendage developmentVerdiana Papagno, Ana-Marija Sulic, Jyoti P Satta, et al.
Cell Reports|June 15, 2023
Transcriptomic landscape of early hair follicle and epidermal developmentAna-Marija Sulic, Rishi Das Roy, Verdiana Papagno, et al.
Gut|April 8, 2011
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free dietTarcisio Not, Fabiana Ziberna, Serena Vatta, et al.
Scandinavian Journal of Gastroenterology|January 26, 2010
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodiesSergio Caja, Essi Myrsky, Ilma R Korponay-Szabo, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 7, 2012
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodiesStefania Martucciello, Miha Lavric, Boglarka Toth, et al.
Nucleic Acids Research|February 11, 2010
Rapid interactome profiling by massive sequencingRoberto Di Niro, Ana-Marija Sulic, Flavio Mignone, et al.
Amino Acids|August 10, 2016
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of miceSuvi Kalliokoski, Victoria Ortín Piqueras, Rafael Frías, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|May 9, 2014
Current status of drugs in development for celiac diseaseKalle Kurppa, Minna Hietikko, Ana-Marija Sulic, et al.
Expert Opinion on Therapeutic Targets|November 21, 2014
Transglutaminase as a therapeutic target for celiac diseaseAna-Marija Sulic, Kalle Kurppa, Tiina Rauhavirta, et al.
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|October 31, 2020
System-level analyses of keystone genes required for mammalian tooth developmentOuti Hallikas, Rishi Das Roy, Mona M Christensen, et al.
The International Journal of Developmental Biology|May 21, 2024
Wnt target gene Ascl4 is dispensable for skin appendage developmentVerdiana Papagno, Ana-Marija Sulic, Jyoti P Satta, et al.
Cell Reports|June 15, 2023
Transcriptomic landscape of early hair follicle and epidermal developmentAna-Marija Sulic, Rishi Das Roy, Verdiana Papagno, et al.
Gut|April 8, 2011
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free dietTarcisio Not, Fabiana Ziberna, Serena Vatta, et al.
Scandinavian Journal of Gastroenterology|January 26, 2010
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodiesSergio Caja, Essi Myrsky, Ilma R Korponay-Szabo, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 7, 2012
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodiesStefania Martucciello, Miha Lavric, Boglarka Toth, et al.
Nucleic Acids Research|February 11, 2010
Rapid interactome profiling by massive sequencingRoberto Di Niro, Ana-Marija Sulic, Flavio Mignone, et al.
Amino Acids|August 10, 2016
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of miceSuvi Kalliokoski, Victoria Ortín Piqueras, Rafael Frías, et al.
Pageof 1